Closed IndrajeetPatil closed 3 years ago
Here are some more:
Since Phi and V are equal to Pearson's r for a 22 xtab, I would suspect that it should have the same interpretation for the *magnitude\ of association.
Since Phi and V are equal to Pearson's r for a 2*2 xtab
But we should also pre-meditate and cover one-way tests and non-2*2-tests, no?
library(effectsize)
effectsize(chisq.test(mtcars$cyl))
#> Cramer's V | 95% CI
#> -------------------------
#> 0.05 | [0.00, 0.00]
effectsize(chisq.test(mtcars$am, mtcars$cyl))
#> Warning in chisq.test(mtcars$am, mtcars$cyl): Chi-squared approximation may be
#> incorrect
#> Cramer's V | 95% CI
#> -------------------------
#> 0.52 | [0.11, 0.85]
Created on 2021-06-13 by the reprex package (v2.0.0)
It's the same measure in all those cases, I'm just pointing the equality in a specific case, so I think V can be interpreted similarly in all cases (like Pearson's r). (But not phi, which in cases other than 2*2 can be larger than 1).
@bwiernik have any insight here?
Oh, I wrote a reply this morning that I must not have sent.
Yes, we can apply the same benchmarks for Cramer’s V and phi as for Pearson r. There is some nuance that distributions impact the maximum observable r (Oscar Olveira’s work here is great), and these are most noticeable for discrete variables. But these are fairly small concerns and as a first approximation, Pearson benchmarks are fine.
👆
Do we even need a separate function? Will an alias do here?
I guess alias is fine, until some "specific" rules of thumb are published (if ever)
I would also like to work soon on adding support for chi-squared tests in
report
package, and we will need interpretation guidelines for Cramer's V before I can do that.I have seen guidelines online (like the one in the link below), but I can't seem to find any references for these. https://www.ibm.com/docs/en/cognos-analytics/11.1.0?topic=terms-cramrs-v
What do you think?